# Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects

> **NCT01860703** · PHASE4 · COMPLETED · sponsor: **ApoPharma** · enrollment: 50 (actual)

## Conditions studied

- Prolonged QTc Interval

## Interventions

- **DRUG:** Deferiprone
- **DRUG:** deferiprone matching placebo tablets
- **DRUG:** moxifloxacin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01860703
- **Lead sponsor:** ApoPharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2012-12
- **Final completion:** 2013-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01860703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01860703, "Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01860703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*